| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Guillemin Evan serves as a Director at MLAB. Across recent SEC filings that breaks down to 0 buys and 19 sells.
Historically, Guillemin Evan's trades have earned a middling insider score of 68/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +21.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2019 | MLAB Mesa Laboratories Inc /co/ | Director | Sell | 7,500 | $251.31 | $1,884,825.00 | -15.5% | |
| Feb 20, 2019 | MLAB Mesa Laboratories Inc /co/ | Director | Sale+OE | 1,746 | $232.31 | $405,613.26 | -3.5% | |
| Feb 13, 2019 | MLAB Mesa Laboratories Inc /co/ | Director | Sale+OE | 3,254 | $230.70 | $750,687.40 | -6.3% | |
| Dec 10, 2018 | MLAB Mesa Laboratories Inc /co/ | Director | Sell | 15,000 | $212.72 | $3,190,780.00 | -23.6% |